Show Summary Details
Page of

Genetics and Genomics of Chronic Kidney Disease 

Genetics and Genomics of Chronic Kidney Disease
Genetics and Genomics of Chronic Kidney Disease

Albert C. M. Ong

and Alexander P. Maxwell

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 June 2020

Chronic renal diseases are heterogeneous and collectively a huge burden on medical and socio-economic resources. The prevalence of end-stage renal disease (ESRD) is steadily increasing contributing to growth in provision of renal replacement therapy (dialysis and transplantation) for over one million individuals worldwide. Living with ESRD is challenging for individuals and the economic costs of renal replacement therapy for society are enormous. There is increasing evidence for genetic (polygenic) susceptibility for diabetic nephropathy. Autosomal dominant polycystic kidney disease (ADPKD) accounts for 5-10% of prevalent ESRD and is the single most common monogenic cause of chronic renal disease. Heterogeneous genetic factors can modify the phenotypic expression of these two common chronic diseases and illustrate the different experimental approaches that are being used to identify modifying genes important in chronic kidney disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.